Marinus Pharmaceuticals reported $10.97M in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 4.17M 125.57M
ALKERMES ALKS:US $ 297.07M 0.63M
Amgen AMGN:US $ 32782M 97M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 43.5M 1.09M
Biogen BIIB:US $ 7269.2M 2M
Eisai 4523:JP Y 92683M 2790M
Esperion Therapeutics ESPR:US $ 272.1M 404K
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Minerva Neurosciences NERV:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Ptc Therapeutics PTCT:US $ 1161.83M 15.06M
Regeneron Pharmaceuticals REGN:US $ 2697.6M 0.9M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Supernus Pharmaceuticals SUPN:US $ 370.38M 18.83M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 34.25M 0.22M
Zogenix ZGNX:US $ 153.63M 2.18M